Peter C. Black

22.1k total citations · 5 hit papers
430 papers, 11.6k citations indexed

About

Peter C. Black is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Peter C. Black has authored 430 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 303 papers in Surgery, 143 papers in Pulmonary and Respiratory Medicine and 96 papers in Oncology. Recurrent topics in Peter C. Black's work include Bladder and Urothelial Cancer Treatments (261 papers), Urinary and Genital Oncology Studies (161 papers) and Urological Disorders and Treatments (63 papers). Peter C. Black is often cited by papers focused on Bladder and Urothelial Cancer Treatments (261 papers), Urinary and Genital Oncology Studies (161 papers) and Urological Disorders and Treatments (63 papers). Peter C. Black collaborates with scholars based in Canada, United States and Germany. Peter C. Black's co-authors include Colin P. Dinney, Ashish M. Kamat, Gordon Brown, B. Boashash, Wassim Kassouf, James W.F. Catto, Alan So, Yair Lotan, Tilman Todenhöfer and David J. McConkey and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Peter C. Black

402 papers receiving 11.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018

2018 533 citations Marcus Cumberbatch, Ibrahim Jubber et al. European Urology profile →
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy

2013 427 citations Peter C. Black et al. profile →
Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors

2023 222 citations Ibrahim Jubber, Peter C. Black et al. European Urology profile →
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective

2022 102 citations Ashish M. Kamat, Peter C. Black et al. profile →
Urine biomarkers in bladder cancer — current status and future perspectives

2023 66 citations Tilman Todenhöfer, Peter C. Black et al. profile →

Peers

Countries citing papers authored by Peter C. Black

Since Specialization

Citations

This map shows the geographic impact of Peter C. Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Black more than expected).

Fields of papers citing papers by Peter C. Black

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Black. The network helps show where Peter C. Black may publish in the future.

Co-authorship network of co-authors of Peter C. Black

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Black. A scholar is included among the top collaborators of Peter C. Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Black. Peter C. Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2025 Canadian Urological Association Expert Report: Muscle-invasive bladder cancer 2025 ·Canadian Urological Association Journal ·Girish S. Kulkarni, Peter C. Black, Srikala S. Sridhar, (unknown), Bobby Shayegan, Ricardo Rendon, Peter Chung, Theodorus van der Kwast, Nimira Alimohamed, Yves Fradet, Andrea Kokorovic, Fabio Cury, Wassim Kassouf	0
2	The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast 2024 ·Advances in Therapy ·Peter C. Black, Bernhard J. Eigl	1
3	Prostate Cancer Risk Stratification by Digital Histopathology and Deep Learning 2024 ·JCO Clinical Cancer Informatics ·(unknown), (unknown), Davood Karimi, Jane Wang, Ladan Fazli, S. Larry Goldenberg, Martin Gleave, Peter C. Black, Ali Bashashati, Septimiu E. Salcudean	4
4	Abstract A007: Circulating tumor DNA and tissue staining analyses reveal heterogeneous ERBB2/HER2 status in urothelial cancer 2024 ·Clinical Cancer Research ·Gillian Vandekerkhove, Andrew J. Murtha, David C. Müller, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Cecily Q. Bernales, (unknown), Gang Wang, Tilman Todenhöfer, Piet Ost, Peter C. Black, Kim N., Bernhard J. Eigl, Alexander W. Wyatt	0
5	Pulsed Photothermal Therapy of Solid Tumors as a Precondition for Immunotherapy 2024 ·Small ·(unknown), (unknown), Morgan E. Roberts, (unknown), (unknown), (unknown), Htoo Zarni Oo, Nader Al Nakouzi, (unknown), Peter C. Black, Mads Daugaard	11
6	Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605 2023 ·European Urology ·Peter C. Black, Catherine M. Tangen, Parminder Singh, David J. McConkey, M. Scott Lucia, William T. Lowrance, Vadim S. Koshkin, Kelly Stratton, Trinity J. Bivalacqua, Wassim Kassouf, Sima P. Porten, Rick Bangs, Melissa Plets, Ian M. Thompson, Seth P. Lerner	48
7	The genitourinary impacts of electronic cigarette use: a systematic review of the literature 2023 ·World Journal of Urology ·(unknown), (unknown), (unknown), Peter C. Black, (unknown)	11
8	Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1 2023 ·Urologic Oncology Seminars and Original Investigations ·Patrick J. Hensley, Roland Seiler, Harry W. Herr, Kent W. Mouw, Gopa Iyer, Lars Dyrskjøt, Roman Nawroth, Peter J. Goebell, Bernd J. Schmitz‐Dräger, Tilman Todenhöfer, Peter C. Black, Ashish M. Kamat, Stephen B. Williams	1
9	Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin 2021 ·Clinical Cancer Research ·Carissa Chu, Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu, Vadim S. Koshkin, Bradley A. Stohr, Maxwell V. Meng, Raj S. Pruthi, Terence W. Friedlander, Yair Lotan, Peter C. Black, Sima P. Porten, Felix Y. Feng, Jonathan Chou	101
10	SEMS trial: Result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma. 2021 ·Journal of Clinical Oncology ·Siamak Daneshmand, Clint Cary, Timothy A. Masterson, Lawrence Einhorn, Stephen A. Boorjian, Christian Kollmannsberger, Anne Schuckman, (unknown), Peter C. Black, Aditya Bagrodia, Eila C. Skinner, Mehrdad Alemozaffar, Timothy C. Brand, Scott E. Eggener, Phillip M. Pierorazio, Kelly Stratton, Lucia Nappi, Craig R. Nichols, Brian Hu	21
11	Sequential Gemcitabine plus Docetaxel Is the Standard Second-line Intravesical Therapy for BCG-unresponsive Non–muscle-invasive bladder cancer: Pro 2021 ·European Urology Focus ·M. Roumiguié, Peter C. Black	7
12	Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer 2020 ·Molecular Cancer Therapeutics ·Yoshihisa Kawai, Kenjiro Imada, Shusuke Akamatsu, Fan Zhang, Roland Seiler, Tetsutaro Hayashi, (unknown), Eliana Beraldi, Neetu Saxena, Alexander Kretschmer, Htoo Zarni Oo, Alberto Contreras‐Sanz, Hideyasu Matsuyama, Dong Lin, Ladan Fazli, Colin C. Collins, Alexander W. Wyatt, Peter C. Black, Martin Gleave	12
13	Reporting radical cystectomy outcomes following implementation of Enhanced Recovery after Surgery (ERAS) protocols: A systematic review and individual patient data meta-analysis 2020 ·European Urology Open Science ·(unknown), Marcus Cumberbatch, Ashish M. Kamat, (unknown), John McGrath, Hooman Djaladat, Justin Collins, Ibrahim Jubber, Vignesh T. Packiam, Gary D. Steinberg, (unknown), Wassim Kassouf, Peter C. Black, Yannick Cerantola, James W.F. Catto, Siamak Daneshmand	15
14	Radical cystectomy improves survival in patients with stage T1 squamous cell carcinoma and neuroendocrine carcinoma of the urinary bladder 2020 ·European Journal of Surgical Oncology ·Marina Deuker, Lara Franziska Stolzenbach, Giuseppe Rosiello, Stefano Luzzago, Thomas G. Martin, Zhe Tian, Derya Tilki, Shahrokh F. Shariat, Fred Saad, Wassim Kassouf, Peter C. Black, Felix K.‐H. Chun, Pierre I. Karakiewicz	6
15	Genomic Subtyping in Bladder Cancer 2020 ·Current Urology Reports ·Tuomas Jalanko, Joep J. de Jong, Ewan A. Gibb, Roland Seiler, Peter C. Black	21
16	Post-translational modifications in bladder cancer: Expanding the tumor target repertoire 2018 ·Urologic Oncology Seminars and Original Investigations ·Htoo Zarni Oo, Roland Seiler, Peter C. Black, Mads Daugaard	17
17	A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer 2017 ·World Journal of Urology ·Sebastian Frees, Jonathan Aning, Peter C. Black, Werner J. Struss, Robert H. Bell, Claudia Chávez‐Muñoz, Martin Gleave, Alan So	62
18	Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy 2016 ·Clinical Cancer Research ·Tetsutaro Hayashi, Kilian M. Gust, Alexander W. Wyatt, (unknown), Wolfgang Jäger, Shannon Awrey, Na Li, Htoo Zarni Oo, Manuel Altamirano-Dimas, Ralph Buttyan, Ladan Fazli, Akio Matsubara, Peter C. Black	75
19	Multiparametric magnetic resonance imaging–targeted biopsy for the detection of prostate cancer in patients with prior negative biopsy results 2015 ·Urologic Oncology Seminars and Original Investigations ·Hamidreza Abdi, Homayoun Zargar, S. Larry Goldenberg, (unknown), Farshad Pourmalek, (unknown), Silvia D. Chang, Martin Gleave, Alison Harris, Alan So, Lindsay Machan, Peter C. Black	31
20	Multiparametric Magnetic Resonance Imaging Enhances Detection of Significant Tumor in Patients on Active Surveillance for Prostate Cancer 2015 ·Urology ·Hamidreza Abdi, Farshad Pourmalek, Homayoun Zargar, (unknown), Alison Harris, Silvia D. Chang, (unknown), Alan So, Martin Gleave, Lindsay Machan, S. Larry Goldenberg, Peter C. Black	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact